Roche NimbleGen solutions for advancing genomics research

Francis Kelly and Kyle Munn, Roche NimbleGen

June 30, 2009 @ 11:00 am to 12:00 pm

11 Life Sciences Building

Agenda 10:00 - 10:10 Overview of the Roche NimbleGen product line Francis Kelly, Key Account Manager, Microarrays 10:10 - 10:35 Sequence capture platform Kyle Munn, Microarray Application Specialist Roche NimbleGen Sequence Capture technology is a revolutionary process for the enrichment of several megabases of selected genomic regions from full-complexity human genomic DNA in a single step.The process utilizes high-density, long-oligo NimbleGen arrays for the targeted hybridization and elution of only those genome regions you specify. The method is applicable to large contiguous or noncontiguous genomic regions, whole exomes, or any other targeted regions you want to sequence and is a highly efficient and cost-effective method for capturing targeted regions of the genome. 10:35 - 11:00 Expression analysis platform Kyle Munn, Microarray Application Specialist Roche NimbleGen provides a unique combination of high-density arrays, long-oligo probes, and flexible design capability that together provide superior results for advanced gene expression analysis. Roche NimbleGen microarrays enable accurate, sensitive, and specific interrogation of genome-wide expression for both prokaryotic and eukaryotic genomes. In addition, they are the gene expression platform of choice as evidenced by a growing list of scientific publications; the accuracy of the Roche NimbleGen data is supported by high correlation with TaqMan data. Roche NimbleGen Gene Expression products are available in the 385K, 4x72K and 12x135K array formats. _ If you would like to meet with Francis or Kyle individually, please contact Francis at francis.kelly@roche.com _

Contact

Craig Praul
cap142@psu.edu
814-865-4262